Group Strategy Director, Hall & Partners
Matthew Turner is a group strategy director at Hall & Partners, a business unit of Escalent, with more than 20 years of experience advising global pharmaceutical and healthcare organizations on high-impact strategic decisions. He specializes in strategic insight, advanced analytics and evidence-based decision-making, helping clients translate complex data into commercial advantage across the product lifecycle, from early asset strategy and launch through to brand optimization and lifecycle management. Matthew has led global programs across a broad range of therapeutic areas, partnering with clients to address strategic challenges including segmentation, brand strategy and demand forecasting. He is passionate about combining methodological rigor with AI-enabled innovation to deliver deeper, faster and more actionable insights that drive confident business decisions.
